{"transactions":[{"id":695789,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":false,"shares":1088986.3,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By MVIL, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Notes were scheduled to mature on September 17, 2027, but converted automatically upon the closing of the IPO on August 3, 2026, prior to the maturity date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents securities held by MVIL, LLC."}],"balance_after":0,"derivative":{"exercise_price":14.4,"underlying":"Class A Common Stock","underlying_shares":75624},"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695788,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Preferred Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":false,"shares":9227454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of convertible preferred stock (\"Convertible Preferred Stock\") was convertible into one share of Class A common stock (\"Class A Common Stock\") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of convertible preferred stock (\"Convertible Preferred Stock\") was convertible into one share of Class A common stock (\"Class A Common Stock\") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of convertible preferred stock (\"Convertible Preferred Stock\") was convertible into one share of Class A common stock (\"Class A Common Stock\") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6840213},"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695787,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"other","planned":false,"acquired":true,"shares":75624,"ownership":{"direct":false,"nature":"By MVIL, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents securities held by MVIL, LLC."}],"balance_after":75624,"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695786,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"other","planned":false,"acquired":false,"shares":75624,"ownership":{"direct":false,"nature":"By MVIL, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents securities held by MVIL, LLC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695785,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":true,"shares":75624,"price":14.4,"value":1088985.6,"ownership":{"direct":false,"nature":"By MVIL, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents securities held by MVIL, LLC."}],"balance_after":75624,"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695784,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":312500,"price":16,"value":5000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."}],"balance_after":7152713,"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695783,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"other","planned":false,"acquired":true,"shares":6840213,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."}],"balance_after":6840213,"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695782,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"other","planned":false,"acquired":false,"shares":6840213,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the \"Notes\") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock (\"Common Stock\") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") pursuant to Rule 16b-7 thereunder (the \"Reclassification\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695781,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26252,"kind":"organization","name":"Morningside Venture Investments Ltd","position":1,"cik":"0001543112","reported_name":"Morningside Venture Investments Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-05T20:18:26.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":true,"shares":6840213,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of convertible preferred stock (\"Convertible Preferred Stock\") was convertible into one share of Class A common stock (\"Class A Common Stock\") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the \"IPO\") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited (\"Morningside\") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC."}],"balance_after":6840213,"source":{"system":"sec-edgar","filing":"0000905148-26-003483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000090514826003483/form4.xml","form_type":"4"}},{"id":695956,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26292,"kind":"organization","name":"Alpha Wave Ventures GP, Ltd","position":1,"cik":"0002007422","reported_name":"Alpha Wave Ventures GP, Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26293,"kind":"organization","name":"Alpha Wave Global, LP","position":2,"cik":"0001558858","reported_name":"Alpha Wave Global, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26294,"kind":"organization","name":"Lunate Holding RSC Ltd","position":3,"cik":"0002009522","reported_name":"Lunate Holding RSC Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26295,"kind":"organization","name":"Chimera Investment LLC","position":4,"cik":"0002009884","reported_name":"Chimera Investment LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-08-05T20:10:20.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":false,"price":0,"reported_value":21779726,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"reported_value","element":"transactionTotalValue","label":"F5","text":"Includes $1,779,726 of accrued and unpaid interest."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The principal amount of the Convertible Promissory Note (the \"Note\") (together with accrued interest thereon) automatically converted upon the closing of the IPO into shares of Common Stock. The number of shares reported represents the outstanding principal amount of $20,000,000 plus accrued interest of $1,779,726 as of the IPO closing date, divided by the conversion price of $14.40 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The maturity date of the Note was September 17, 2027, but it automatically converted upon the closing of the IPO prior to the maturity date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the closing of the IPO (the \"Reclassification\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities held by Alpha Wave Ventures II, LP (\"Alpha Wave Ventures\"). Alpha Wave Ventures GP, Ltd (\"Alpha Wave Ventures GP\") is the general partner of Alpha Wave Ventures. Alpha Wave Ventures GP is a joint venture between Alpha Wave Global, LP (\"Alpha Wave\") and Lunate Holding RSC LTD (\"Lunate\"). Lunate is majority-owned by Chimera Investment LLC (\"Chimera,\" together with Alpha Wave Ventures GP, Alpha Wave and Lunate, the \"Reporting Persons\"). Richard Gerson is the Chairman and Chief Investment Officer of Alpha Wave. Chimera is controlled by its board of directors. The managing partners of Lunate Capital Limited, a wholly-owned investment manager subsidiary of Lunate, manage the investment activities of Lunate."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or any other purpose."}],"balance_after":0,"derivative":{"exercise_price":14.4,"underlying":"Common Stock","underlying_shares":1512480},"source":{"system":"sec-edgar","filing":"0000919574-26-004812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2009884/000091957426004812/ownership.xml","form_type":"4"}},{"id":695955,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26292,"kind":"organization","name":"Alpha Wave Ventures GP, Ltd","position":1,"cik":"0002007422","reported_name":"Alpha Wave Ventures GP, Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26293,"kind":"organization","name":"Alpha Wave Global, LP","position":2,"cik":"0001558858","reported_name":"Alpha Wave Global, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26294,"kind":"organization","name":"Lunate Holding RSC Ltd","position":3,"cik":"0002009522","reported_name":"Lunate Holding RSC Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26295,"kind":"organization","name":"Chimera Investment LLC","position":4,"cik":"0002009884","reported_name":"Chimera Investment LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-3 Preferred Stock","published_at":"2026-08-05T20:10:20.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":false,"shares":5404918,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Company's Preferred Stock automatically converted into one share of Class A Common Stock on a 0.741-for-one basis immediately prior to the closing of the IPO without payment of additional consideration, which shares were then reclassified into shares of Common Stock pursuant to the Reclassification described in footnote 2. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Company's Preferred Stock automatically converted into one share of Class A Common Stock on a 0.741-for-one basis immediately prior to the closing of the IPO without payment of additional consideration, which shares were then reclassified into shares of Common Stock pursuant to the Reclassification described in footnote 2. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Company's Preferred Stock automatically converted into one share of Class A Common Stock on a 0.741-for-one basis immediately prior to the closing of the IPO without payment of additional consideration, which shares were then reclassified into shares of Common Stock pursuant to the Reclassification described in footnote 2. The Preferred Stock had no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the closing of the IPO (the \"Reclassification\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities held by Alpha Wave Ventures II, LP (\"Alpha Wave Ventures\"). Alpha Wave Ventures GP, Ltd (\"Alpha Wave Ventures GP\") is the general partner of Alpha Wave Ventures. Alpha Wave Ventures GP is a joint venture between Alpha Wave Global, LP (\"Alpha Wave\") and Lunate Holding RSC LTD (\"Lunate\"). Lunate is majority-owned by Chimera Investment LLC (\"Chimera,\" together with Alpha Wave Ventures GP, Alpha Wave and Lunate, the \"Reporting Persons\"). Richard Gerson is the Chairman and Chief Investment Officer of Alpha Wave. Chimera is controlled by its board of directors. The managing partners of Lunate Capital Limited, a wholly-owned investment manager subsidiary of Lunate, manage the investment activities of Lunate."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4006611},"source":{"system":"sec-edgar","filing":"0000919574-26-004812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2009884/000091957426004812/ownership.xml","form_type":"4"}},{"id":695954,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26292,"kind":"organization","name":"Alpha Wave Ventures GP, Ltd","position":1,"cik":"0002007422","reported_name":"Alpha Wave Ventures GP, Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26293,"kind":"organization","name":"Alpha Wave Global, LP","position":2,"cik":"0001558858","reported_name":"Alpha Wave Global, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26294,"kind":"organization","name":"Lunate Holding RSC Ltd","position":3,"cik":"0002009522","reported_name":"Lunate Holding RSC Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26295,"kind":"organization","name":"Chimera Investment LLC","position":4,"cik":"0002009884","reported_name":"Chimera Investment LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-2 Preferred Stock","published_at":"2026-08-05T20:10:20.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":false,"shares":720655,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Company's Preferred Stock automatically converted into one share of Class A Common Stock on a 0.741-for-one basis immediately prior to the closing of the IPO without payment of additional consideration, which shares were then reclassified into shares of Common Stock pursuant to the Reclassification described in footnote 2. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Company's Preferred Stock automatically converted into one share of Class A Common Stock on a 0.741-for-one basis immediately prior to the closing of the IPO without payment of additional consideration, which shares were then reclassified into shares of Common Stock pursuant to the Reclassification described in footnote 2. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Company's Preferred Stock automatically converted into one share of Class A Common Stock on a 0.741-for-one basis immediately prior to the closing of the IPO without payment of additional consideration, which shares were then reclassified into shares of Common Stock pursuant to the Reclassification described in footnote 2. The Preferred Stock had no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the closing of the IPO (the \"Reclassification\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities held by Alpha Wave Ventures II, LP (\"Alpha Wave Ventures\"). Alpha Wave Ventures GP, Ltd (\"Alpha Wave Ventures GP\") is the general partner of Alpha Wave Ventures. Alpha Wave Ventures GP is a joint venture between Alpha Wave Global, LP (\"Alpha Wave\") and Lunate Holding RSC LTD (\"Lunate\"). Lunate is majority-owned by Chimera Investment LLC (\"Chimera,\" together with Alpha Wave Ventures GP, Alpha Wave and Lunate, the \"Reporting Persons\"). Richard Gerson is the Chairman and Chief Investment Officer of Alpha Wave. Chimera is controlled by its board of directors. The managing partners of Lunate Capital Limited, a wholly-owned investment manager subsidiary of Lunate, manage the investment activities of Lunate."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":534214},"source":{"system":"sec-edgar","filing":"0000919574-26-004812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2009884/000091957426004812/ownership.xml","form_type":"4"}},{"id":695953,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26292,"kind":"organization","name":"Alpha Wave Ventures GP, Ltd","position":1,"cik":"0002007422","reported_name":"Alpha Wave Ventures GP, Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26293,"kind":"organization","name":"Alpha Wave Global, LP","position":2,"cik":"0001558858","reported_name":"Alpha Wave Global, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26294,"kind":"organization","name":"Lunate Holding RSC Ltd","position":3,"cik":"0002009522","reported_name":"Lunate Holding RSC Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26295,"kind":"organization","name":"Chimera Investment LLC","position":4,"cik":"0002009884","reported_name":"Chimera Investment LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2026-08-05T20:10:20.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":false,"shares":1351227,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Company's Preferred Stock automatically converted into one share of Class A Common Stock on a 0.741-for-one basis immediately prior to the closing of the IPO without payment of additional consideration, which shares were then reclassified into shares of Common Stock pursuant to the Reclassification described in footnote 2. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Company's Preferred Stock automatically converted into one share of Class A Common Stock on a 0.741-for-one basis immediately prior to the closing of the IPO without payment of additional consideration, which shares were then reclassified into shares of Common Stock pursuant to the Reclassification described in footnote 2. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Company's Preferred Stock automatically converted into one share of Class A Common Stock on a 0.741-for-one basis immediately prior to the closing of the IPO without payment of additional consideration, which shares were then reclassified into shares of Common Stock pursuant to the Reclassification described in footnote 2. The Preferred Stock had no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the closing of the IPO (the \"Reclassification\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities held by Alpha Wave Ventures II, LP (\"Alpha Wave Ventures\"). Alpha Wave Ventures GP, Ltd (\"Alpha Wave Ventures GP\") is the general partner of Alpha Wave Ventures. Alpha Wave Ventures GP is a joint venture between Alpha Wave Global, LP (\"Alpha Wave\") and Lunate Holding RSC LTD (\"Lunate\"). Lunate is majority-owned by Chimera Investment LLC (\"Chimera,\" together with Alpha Wave Ventures GP, Alpha Wave and Lunate, the \"Reporting Persons\"). Richard Gerson is the Chairman and Chief Investment Officer of Alpha Wave. Chimera is controlled by its board of directors. The managing partners of Lunate Capital Limited, a wholly-owned investment manager subsidiary of Lunate, manage the investment activities of Lunate."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1001651},"source":{"system":"sec-edgar","filing":"0000919574-26-004812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2009884/000091957426004812/ownership.xml","form_type":"4"}},{"id":695952,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26292,"kind":"organization","name":"Alpha Wave Ventures GP, Ltd","position":1,"cik":"0002007422","reported_name":"Alpha Wave Ventures GP, Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26293,"kind":"organization","name":"Alpha Wave Global, LP","position":2,"cik":"0001558858","reported_name":"Alpha Wave Global, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26294,"kind":"organization","name":"Lunate Holding RSC Ltd","position":3,"cik":"0002009522","reported_name":"Lunate Holding RSC Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26295,"kind":"organization","name":"Chimera Investment LLC","position":4,"cik":"0002009884","reported_name":"Chimera Investment LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-05T20:10:20.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":true,"shares":1512480,"price":13.5,"value":20418480.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the closing of the IPO (the \"Reclassification\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities held by Alpha Wave Ventures II, LP (\"Alpha Wave Ventures\"). Alpha Wave Ventures GP, Ltd (\"Alpha Wave Ventures GP\") is the general partner of Alpha Wave Ventures. Alpha Wave Ventures GP is a joint venture between Alpha Wave Global, LP (\"Alpha Wave\") and Lunate Holding RSC LTD (\"Lunate\"). Lunate is majority-owned by Chimera Investment LLC (\"Chimera,\" together with Alpha Wave Ventures GP, Alpha Wave and Lunate, the \"Reporting Persons\"). Richard Gerson is the Chairman and Chief Investment Officer of Alpha Wave. Chimera is controlled by its board of directors. The managing partners of Lunate Capital Limited, a wholly-owned investment manager subsidiary of Lunate, manage the investment activities of Lunate."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or any other purpose."}],"balance_after":7054956,"source":{"system":"sec-edgar","filing":"0000919574-26-004812","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2009884/000091957426004812/ownership.xml","form_type":"4"}},{"id":695951,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26292,"kind":"organization","name":"Alpha Wave Ventures GP, Ltd","position":1,"cik":"0002007422","reported_name":"Alpha Wave Ventures GP, Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26293,"kind":"organization","name":"Alpha Wave Global, LP","position":2,"cik":"0001558858","reported_name":"Alpha Wave Global, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26294,"kind":"organization","name":"Lunate Holding RSC Ltd","position":3,"cik":"0002009522","reported_name":"Lunate Holding RSC Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26295,"kind":"organization","name":"Chimera Investment LLC","position":4,"cik":"0002009884","reported_name":"Chimera Investment LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-05T20:10:20.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":true,"shares":4006611,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the closing of the IPO (the \"Reclassification\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Company's Preferred Stock automatically converted into one share of Class A Common Stock on a 0.741-for-one basis immediately prior to the closing of the IPO without payment of additional consideration, which shares were then reclassified into shares of Common Stock pursuant to the Reclassification described in footnote 2. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities held by Alpha Wave Ventures II, LP (\"Alpha Wave Ventures\"). Alpha Wave Ventures GP, Ltd (\"Alpha Wave Ventures GP\") is the general partner of Alpha Wave Ventures. Alpha Wave Ventures GP is a joint venture between Alpha Wave Global, LP (\"Alpha Wave\") and Lunate Holding RSC LTD (\"Lunate\"). Lunate is majority-owned by Chimera Investment LLC (\"Chimera,\" together with Alpha Wave Ventures GP, Alpha Wave and Lunate, the \"Reporting Persons\"). Richard Gerson is the Chairman and Chief Investment Officer of Alpha Wave. Chimera is controlled by its board of directors. The managing partners of Lunate Capital Limited, a wholly-owned investment manager subsidiary of Lunate, manage the investment activities of Lunate."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or any other purpose."}],"balance_after":5542476,"source":{"system":"sec-edgar","filing":"0000919574-26-004812","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2009884/000091957426004812/ownership.xml","form_type":"4"}},{"id":695950,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26292,"kind":"organization","name":"Alpha Wave Ventures GP, Ltd","position":1,"cik":"0002007422","reported_name":"Alpha Wave Ventures GP, Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26293,"kind":"organization","name":"Alpha Wave Global, LP","position":2,"cik":"0001558858","reported_name":"Alpha Wave Global, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26294,"kind":"organization","name":"Lunate Holding RSC Ltd","position":3,"cik":"0002009522","reported_name":"Lunate Holding RSC Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26295,"kind":"organization","name":"Chimera Investment LLC","position":4,"cik":"0002009884","reported_name":"Chimera Investment LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-05T20:10:20.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":true,"shares":534214,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the closing of the IPO (the \"Reclassification\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Company's Preferred Stock automatically converted into one share of Class A Common Stock on a 0.741-for-one basis immediately prior to the closing of the IPO without payment of additional consideration, which shares were then reclassified into shares of Common Stock pursuant to the Reclassification described in footnote 2. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities held by Alpha Wave Ventures II, LP (\"Alpha Wave Ventures\"). Alpha Wave Ventures GP, Ltd (\"Alpha Wave Ventures GP\") is the general partner of Alpha Wave Ventures. Alpha Wave Ventures GP is a joint venture between Alpha Wave Global, LP (\"Alpha Wave\") and Lunate Holding RSC LTD (\"Lunate\"). Lunate is majority-owned by Chimera Investment LLC (\"Chimera,\" together with Alpha Wave Ventures GP, Alpha Wave and Lunate, the \"Reporting Persons\"). Richard Gerson is the Chairman and Chief Investment Officer of Alpha Wave. Chimera is controlled by its board of directors. The managing partners of Lunate Capital Limited, a wholly-owned investment manager subsidiary of Lunate, manage the investment activities of Lunate."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or any other purpose."}],"balance_after":1535865,"source":{"system":"sec-edgar","filing":"0000919574-26-004812","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2009884/000091957426004812/ownership.xml","form_type":"4"}},{"id":695949,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":26292,"kind":"organization","name":"Alpha Wave Ventures GP, Ltd","position":1,"cik":"0002007422","reported_name":"Alpha Wave Ventures GP, Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26293,"kind":"organization","name":"Alpha Wave Global, LP","position":2,"cik":"0001558858","reported_name":"Alpha Wave Global, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26294,"kind":"organization","name":"Lunate Holding RSC Ltd","position":3,"cik":"0002009522","reported_name":"Lunate Holding RSC Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26295,"kind":"organization","name":"Chimera Investment LLC","position":4,"cik":"0002009884","reported_name":"Chimera Investment LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-05T20:10:20.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":true,"shares":1001651,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Pursuant to a reclassification exempt under Rule 16b-7, each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the closing of the IPO (the \"Reclassification\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), each share of the Company's Preferred Stock automatically converted into one share of Class A Common Stock on a 0.741-for-one basis immediately prior to the closing of the IPO without payment of additional consideration, which shares were then reclassified into shares of Common Stock pursuant to the Reclassification described in footnote 2. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities held by Alpha Wave Ventures II, LP (\"Alpha Wave Ventures\"). Alpha Wave Ventures GP, Ltd (\"Alpha Wave Ventures GP\") is the general partner of Alpha Wave Ventures. Alpha Wave Ventures GP is a joint venture between Alpha Wave Global, LP (\"Alpha Wave\") and Lunate Holding RSC LTD (\"Lunate\"). Lunate is majority-owned by Chimera Investment LLC (\"Chimera,\" together with Alpha Wave Ventures GP, Alpha Wave and Lunate, the \"Reporting Persons\"). Richard Gerson is the Chairman and Chief Investment Officer of Alpha Wave. Chimera is controlled by its board of directors. The managing partners of Lunate Capital Limited, a wholly-owned investment manager subsidiary of Lunate, manage the investment activities of Lunate."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"For purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or any other purpose."}],"balance_after":1001651,"source":{"system":"sec-edgar","filing":"0000919574-26-004812","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009884/000091957426004812/ownership.xml","form_type":"4"}},{"id":698940,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27195,"kind":"person","name":"Kelly Michael B","position":1,"cik":"0002147307","reported_name":"Kelly Michael B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:09.000Z","date":"2036-08-03","kind":"grant","planned":false,"acquired":true,"shares":31434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 22, 2026, and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":31434,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Common Stock","underlying_shares":31434},"source":{"system":"sec-edgar","filing":"0001193125-26-330510","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330510/ownership.xml","form_type":"4"}},{"id":698939,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27195,"kind":"person","name":"Kelly Michael B","position":1,"cik":"0002147307","reported_name":"Kelly Michael B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:09.000Z","date":"2036-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":31434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 22, 2026, and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":31434},"source":{"system":"sec-edgar","filing":"0001193125-26-330510","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330510/ownership.xml","form_type":"4"}},{"id":698938,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27195,"kind":"person","name":"Kelly Michael B","position":1,"cik":"0002147307","reported_name":"Kelly Michael B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:09.000Z","date":"2036-07-30","kind":"grant","planned":false,"acquired":true,"shares":31434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 22, 2026, and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":31434,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":31434},"source":{"system":"sec-edgar","filing":"0001193125-26-330510","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330510/ownership.xml","form_type":"4"}},{"id":698937,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27195,"kind":"person","name":"Kelly Michael B","position":1,"cik":"0002147307","reported_name":"Kelly Michael B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:09.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":333580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 22, 2026, and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":333580,"derivative":{"exercise_price":8.15,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":333580},"source":{"system":"sec-edgar","filing":"0001193125-26-330510","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330510/ownership.xml","form_type":"4"}},{"id":698936,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27195,"kind":"person","name":"Kelly Michael B","position":1,"cik":"0002147307","reported_name":"Kelly Michael B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:09.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":333580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 22, 2026, and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":8.15,"expiration_date":"2036-06-23","underlying":"Class A Common Stock","underlying_shares":333580},"source":{"system":"sec-edgar","filing":"0001193125-26-330510","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330510/ownership.xml","form_type":"4"}},{"id":698928,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27193,"kind":"person","name":"Lind Kevin Robert","position":1,"cik":"0001677036","reported_name":"Lind Kevin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:09.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":108916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026 and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":108916,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Common Stock","underlying_shares":108916},"source":{"system":"sec-edgar","filing":"0001193125-26-330505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330505/ownership.xml","form_type":"4"}},{"id":698927,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27193,"kind":"person","name":"Lind Kevin Robert","position":1,"cik":"0001677036","reported_name":"Lind Kevin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:09.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":108916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026 and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":108916},"source":{"system":"sec-edgar","filing":"0001193125-26-330505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330505/ownership.xml","form_type":"4"}},{"id":698926,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27193,"kind":"person","name":"Lind Kevin Robert","position":1,"cik":"0001677036","reported_name":"Lind Kevin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:09.000Z","date":"2026-07-30","kind":"grant","planned":false,"acquired":true,"shares":108916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026 and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":108916,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":108916},"source":{"system":"sec-edgar","filing":"0001193125-26-330505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330505/ownership.xml","form_type":"4"}},{"id":698925,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27193,"kind":"person","name":"Lind Kevin Robert","position":1,"cik":"0001677036","reported_name":"Lind Kevin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:09.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":1186278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026 and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":1186278,"derivative":{"exercise_price":8.15,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":1186278},"source":{"system":"sec-edgar","filing":"0001193125-26-330505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330505/ownership.xml","form_type":"4"}},{"id":698924,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27193,"kind":"person","name":"Lind Kevin Robert","position":1,"cik":"0001677036","reported_name":"Lind Kevin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:09.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1186278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026 and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":8.15,"expiration_date":"2036-06-23","underlying":"Class A Common Stock","underlying_shares":1186278},"source":{"system":"sec-edgar","filing":"0001193125-26-330505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330505/ownership.xml","form_type":"4"}},{"id":698923,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27193,"kind":"person","name":"Lind Kevin Robert","position":1,"cik":"0001677036","reported_name":"Lind Kevin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:09.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":74128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after March 6, 2025, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":74128,"derivative":{"exercise_price":9.5,"expiration_date":"2035-03-06","underlying":"Common Stock","underlying_shares":74128},"source":{"system":"sec-edgar","filing":"0001193125-26-330505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330505/ownership.xml","form_type":"4"}},{"id":698922,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27193,"kind":"person","name":"Lind Kevin Robert","position":1,"cik":"0001677036","reported_name":"Lind Kevin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:09.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":74128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after March 6, 2025, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":9.5,"expiration_date":"2035-03-06","underlying":"Class A Common Stock","underlying_shares":74128},"source":{"system":"sec-edgar","filing":"0001193125-26-330505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330505/ownership.xml","form_type":"4"}},{"id":698935,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27194,"kind":"person","name":"FONTEYNE PAUL R.","position":1,"cik":"0001727550","reported_name":"FONTEYNE PAUL R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:08.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":44477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":44477,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Common Stock","underlying_shares":44477},"source":{"system":"sec-edgar","filing":"0001193125-26-330508","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330508/ownership.xml","form_type":"4"}},{"id":698934,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27194,"kind":"person","name":"FONTEYNE PAUL R.","position":1,"cik":"0001727550","reported_name":"FONTEYNE PAUL R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:08.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":44477},"source":{"system":"sec-edgar","filing":"0001193125-26-330508","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330508/ownership.xml","form_type":"4"}},{"id":698933,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27194,"kind":"person","name":"FONTEYNE PAUL R.","position":1,"cik":"0001727550","reported_name":"FONTEYNE PAUL R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:08.000Z","date":"2026-07-30","kind":"grant","planned":false,"acquired":true,"shares":44477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":44477,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":44477},"source":{"system":"sec-edgar","filing":"0001193125-26-330508","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330508/ownership.xml","form_type":"4"}},{"id":698932,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27194,"kind":"person","name":"FONTEYNE PAUL R.","position":1,"cik":"0001727550","reported_name":"FONTEYNE PAUL R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:08.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":44477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after July 7, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":44477,"derivative":{"exercise_price":8.15,"expiration_date":"2036-07-07","underlying":"Common Stock","underlying_shares":44477},"source":{"system":"sec-edgar","filing":"0001193125-26-330508","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330508/ownership.xml","form_type":"4"}},{"id":698931,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27194,"kind":"person","name":"FONTEYNE PAUL R.","position":1,"cik":"0001727550","reported_name":"FONTEYNE PAUL R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:08.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after July 7, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":8.15,"expiration_date":"2036-07-07","underlying":"Class A Common Stock","underlying_shares":44477},"source":{"system":"sec-edgar","filing":"0001193125-26-330508","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330508/ownership.xml","form_type":"4"}},{"id":698930,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27194,"kind":"person","name":"FONTEYNE PAUL R.","position":1,"cik":"0001727550","reported_name":"FONTEYNE PAUL R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:08.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":51890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after September 18, 2023, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":51890,"derivative":{"exercise_price":4,"expiration_date":"2033-09-18","underlying":"Common Stock","underlying_shares":51890},"source":{"system":"sec-edgar","filing":"0001193125-26-330508","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330508/ownership.xml","form_type":"4"}},{"id":698929,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27194,"kind":"person","name":"FONTEYNE PAUL R.","position":1,"cik":"0001727550","reported_name":"FONTEYNE PAUL R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:08.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":51890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after September 18, 2023, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":4,"expiration_date":"2033-09-18","underlying":"Class A Common Stock","underlying_shares":51890},"source":{"system":"sec-edgar","filing":"0001193125-26-330508","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330508/ownership.xml","form_type":"4"}},{"id":698921,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27192,"kind":"person","name":"Sender Gary","position":1,"cik":"0001659085","reported_name":"Sender Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:07.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":44477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date"}],"balance_after":44477,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Common Stock","underlying_shares":44477},"source":{"system":"sec-edgar","filing":"0001193125-26-330504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330504/ownership.xml","form_type":"4"}},{"id":698920,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27192,"kind":"person","name":"Sender Gary","position":1,"cik":"0001659085","reported_name":"Sender Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:07.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date"}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":44477},"source":{"system":"sec-edgar","filing":"0001193125-26-330504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330504/ownership.xml","form_type":"4"}},{"id":698919,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27192,"kind":"person","name":"Sender Gary","position":1,"cik":"0001659085","reported_name":"Sender Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:07.000Z","date":"2026-07-30","kind":"grant","planned":false,"acquired":true,"shares":44477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date"}],"balance_after":44477,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":44477},"source":{"system":"sec-edgar","filing":"0001193125-26-330504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330504/ownership.xml","form_type":"4"}},{"id":698918,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27192,"kind":"person","name":"Sender Gary","position":1,"cik":"0001659085","reported_name":"Sender Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:07.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":44477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after July 7, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":44477,"derivative":{"exercise_price":8.15,"expiration_date":"2036-07-07","underlying":"Common Stock","underlying_shares":44477},"source":{"system":"sec-edgar","filing":"0001193125-26-330504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330504/ownership.xml","form_type":"4"}},{"id":698917,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27192,"kind":"person","name":"Sender Gary","position":1,"cik":"0001659085","reported_name":"Sender Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:07.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after July 7, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":8.15,"expiration_date":"2036-07-07","underlying":"Class A Common Stock","underlying_shares":44477},"source":{"system":"sec-edgar","filing":"0001193125-26-330504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330504/ownership.xml","form_type":"4"}},{"id":698916,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27192,"kind":"person","name":"Sender Gary","position":1,"cik":"0001659085","reported_name":"Sender Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:07.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":51890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after October 15, 2024, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":51890,"derivative":{"exercise_price":9.5,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":51890},"source":{"system":"sec-edgar","filing":"0001193125-26-330504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330504/ownership.xml","form_type":"4"}},{"id":698915,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27192,"kind":"person","name":"Sender Gary","position":1,"cik":"0001659085","reported_name":"Sender Gary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:07.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":51890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after October 15, 2024, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":9.5,"expiration_date":"2034-12-12","underlying":"Class A Common Stock","underlying_shares":51890},"source":{"system":"sec-edgar","filing":"0001193125-26-330504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330504/ownership.xml","form_type":"4"}},{"id":698914,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":2147,"kind":"person","name":"SEKHRI PAUL J","position":1,"cik":"0001264519","reported_name":"SEKHRI PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:06.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":22238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":22238,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Common Stock","underlying_shares":22238},"source":{"system":"sec-edgar","filing":"0001193125-26-330507","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330507/ownership.xml","form_type":"4"}},{"id":698913,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":2147,"kind":"person","name":"SEKHRI PAUL J","position":1,"cik":"0001264519","reported_name":"SEKHRI PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:06.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":22238},"source":{"system":"sec-edgar","filing":"0001193125-26-330507","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330507/ownership.xml","form_type":"4"}},{"id":698912,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":2147,"kind":"person","name":"SEKHRI PAUL J","position":1,"cik":"0001264519","reported_name":"SEKHRI PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:06.000Z","date":"2026-07-30","kind":"grant","planned":false,"acquired":true,"shares":22238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":22238,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":22238},"source":{"system":"sec-edgar","filing":"0001193125-26-330507","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330507/ownership.xml","form_type":"4"}},{"id":698911,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":2147,"kind":"person","name":"SEKHRI PAUL J","position":1,"cik":"0001264519","reported_name":"SEKHRI PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:06.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":155558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 24 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":155558,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Common Stock","underlying_shares":155558},"source":{"system":"sec-edgar","filing":"0001193125-26-330507","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330507/ownership.xml","form_type":"4"}},{"id":698910,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":2147,"kind":"person","name":"SEKHRI PAUL J","position":1,"cik":"0001264519","reported_name":"SEKHRI PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:06.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":155558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 24 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":155558},"source":{"system":"sec-edgar","filing":"0001193125-26-330507","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330507/ownership.xml","form_type":"4"}},{"id":698909,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":2147,"kind":"person","name":"SEKHRI PAUL J","position":1,"cik":"0001264519","reported_name":"SEKHRI PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:06.000Z","date":"2026-07-30","kind":"grant","planned":false,"acquired":true,"shares":155558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 24 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":155558,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":155558},"source":{"system":"sec-edgar","filing":"0001193125-26-330507","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330507/ownership.xml","form_type":"4"}},{"id":698908,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":2147,"kind":"person","name":"SEKHRI PAUL J","position":1,"cik":"0001264519","reported_name":"SEKHRI PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:06.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":169468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 24 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":169468,"derivative":{"exercise_price":8.15,"expiration_date":"2036-05-28","underlying":"Common Stock","underlying_shares":169468},"source":{"system":"sec-edgar","filing":"0001193125-26-330507","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330507/ownership.xml","form_type":"4"}},{"id":698907,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":2147,"kind":"person","name":"SEKHRI PAUL J","position":1,"cik":"0001264519","reported_name":"SEKHRI PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:06.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":169468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 24 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":8.15,"expiration_date":"2036-05-28","underlying":"Class A Common Stock","underlying_shares":169468},"source":{"system":"sec-edgar","filing":"0001193125-26-330507","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330507/ownership.xml","form_type":"4"}},{"id":698906,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":2147,"kind":"person","name":"SEKHRI PAUL J","position":1,"cik":"0001264519","reported_name":"SEKHRI PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-03T20:01:06.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":12500,"price":16,"value":200000.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001193125-26-330507","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330507/ownership.xml","form_type":"4"}},{"id":698905,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":1941,"kind":"person","name":"JONES WILLIAM A JR","position":1,"cik":"0001373097","reported_name":"JONES WILLIAM A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:05.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":44477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":44477,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Common Stock","underlying_shares":44477},"source":{"system":"sec-edgar","filing":"0001193125-26-330503","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330503/ownership.xml","form_type":"4"}},{"id":698904,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":1941,"kind":"person","name":"JONES WILLIAM A JR","position":1,"cik":"0001373097","reported_name":"JONES WILLIAM A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:05.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":44477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":44477},"source":{"system":"sec-edgar","filing":"0001193125-26-330503","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330503/ownership.xml","form_type":"4"}},{"id":698903,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":1941,"kind":"person","name":"JONES WILLIAM A JR","position":1,"cik":"0001373097","reported_name":"JONES WILLIAM A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:05.000Z","date":"2026-07-30","kind":"grant","planned":false,"acquired":true,"shares":44477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 36 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":44477,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":44477},"source":{"system":"sec-edgar","filing":"0001193125-26-330503","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330503/ownership.xml","form_type":"4"}},{"id":698902,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":74128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 24 months after June 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":74128,"derivative":{"exercise_price":8.15,"expiration_date":"2036-06-01","underlying":"Common Stock","underlying_shares":74128},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698901,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":74128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 24 months after June 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":8.15,"expiration_date":"2036-06-01","underlying":"Class A Common Stock","underlying_shares":74128},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698900,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":25574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after September 17, 2025, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":25574,"derivative":{"exercise_price":8.88,"expiration_date":"2035-09-19","underlying":"Common Stock","underlying_shares":25574},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698899,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after September 17, 2025, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":8.88,"expiration_date":"2035-09-19","underlying":"Class A Common Stock","underlying_shares":25574},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698898,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":59303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the option are fully vested."}],"balance_after":59303,"derivative":{"exercise_price":8.88,"expiration_date":"2035-07-14","underlying":"Common Stock","underlying_shares":59303},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698897,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":59303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":8.88,"expiration_date":"2035-07-14","underlying":"Class A Common Stock","underlying_shares":59303},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698896,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":333580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 21, 2023, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":333580,"derivative":{"exercise_price":4.87,"expiration_date":"2034-03-13","underlying":"Common Stock","underlying_shares":333580},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698895,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":333580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 21, 2023, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":4.87,"expiration_date":"2034-03-13","underlying":"Class A Common Stock","underlying_shares":333580},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698894,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":333580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 22, 2022, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":333580,"derivative":{"exercise_price":4,"expiration_date":"2032-12-22","underlying":"Common Stock","underlying_shares":333580},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698893,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":333580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 22, 2022, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":4,"expiration_date":"2032-12-22","underlying":"Class A Common Stock","underlying_shares":333580},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698892,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":333580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the option are fully vested."}],"balance_after":333580,"derivative":{"exercise_price":2.74,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":333580},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698891,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":333580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.74,"expiration_date":"2032-06-14","underlying":"Class A Common Stock","underlying_shares":333580},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698890,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":302541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the option are fully vested."}],"balance_after":302541,"derivative":{"exercise_price":1.06,"expiration_date":"2030-03-31","underlying":"Common Stock","underlying_shares":302541},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698889,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":302541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.06,"expiration_date":"2030-03-31","underlying":"Class A Common Stock","underlying_shares":302541},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698888,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":98843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the option are fully vested."}],"balance_after":98843,"derivative":{"exercise_price":1,"expiration_date":"2030-01-28","underlying":"Common Stock","underlying_shares":98843},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698887,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":98843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":1,"expiration_date":"2030-01-28","underlying":"Class A Common Stock","underlying_shares":98843},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698886,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":688042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the option are fully vested."}],"balance_after":688042,"derivative":{"exercise_price":1,"expiration_date":"2029-01-29","underlying":"Common Stock","underlying_shares":688042},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698885,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":688042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":1,"expiration_date":"2029-01-29","underlying":"Class A Common Stock","underlying_shares":688042},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698884,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":false,"shares":10845,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Lawrence G. Miller Irrevocable Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Immediately prior to the Issuer's initial public offering, each share of Series A Preferred Stock automatically converted on a one-for-one basis into shares of the Issuer's Class A Common Stock. The Series A Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10845},"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698883,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":88954,"ownership":{"direct":false,"nature":"By Ellen K. Williams Irrevocable Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose."}],"balance_after":88954,"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698882,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":88954,"ownership":{"direct":false,"nature":"By Ellen K. Williams Irrevocable Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698881,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":88954,"ownership":{"direct":false,"nature":"By David G. Miller Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose."}],"balance_after":88954,"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698880,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":88954,"ownership":{"direct":false,"nature":"By David G. Miller Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698879,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":88954,"ownership":{"direct":false,"nature":"By James S. Miller Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose."}],"balance_after":88954,"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698878,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":88954,"ownership":{"direct":false,"nature":"By James S. Miller Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698877,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":88954,"ownership":{"direct":false,"nature":"By Kathleen W. Miller Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose."}],"balance_after":88954,"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698876,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":88954,"ownership":{"direct":false,"nature":"By Kathleen W. Miller Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698875,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":true,"shares":10845,"ownership":{"direct":false,"nature":"By Lawrence G. Miller Irrevocable Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Immediately prior to the Issuer's initial public offering, each share of Series A Preferred Stock automatically converted on a one-for-one basis into shares of the Issuer's Class A Common Stock. The Series A Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the Issuer's initial public offering, each share of Series A Preferred Stock automatically converted on a one-for-one basis into shares of the Issuer's Class A Common Stock. The Series A Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose."}],"balance_after":103276,"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698874,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":92431,"ownership":{"direct":false,"nature":"By Lawrence G. Miller Irrevocable Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose."}],"balance_after":92431,"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698873,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27191,"kind":"person","name":"Miller Lawrence G.","position":1,"cik":"0001572378","reported_name":"Miller Lawrence G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-03T20:01:04.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":92431,"ownership":{"direct":false,"nature":"By Lawrence G. Miller Irrevocable Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-330506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330506/ownership.xml","form_type":"4"}},{"id":698872,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27190,"kind":"person","name":"Molnar Dennis Patrick","position":1,"cik":"0001822371","reported_name":"Molnar Dennis Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:03.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":55596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 24 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":55596,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Common Stock","underlying_shares":55596},"source":{"system":"sec-edgar","filing":"0001193125-26-330502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330502/ownership.xml","form_type":"4"}},{"id":698871,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27190,"kind":"person","name":"Molnar Dennis Patrick","position":1,"cik":"0001822371","reported_name":"Molnar Dennis Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:03.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":55596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 24 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":55596},"source":{"system":"sec-edgar","filing":"0001193125-26-330502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330502/ownership.xml","form_type":"4"}},{"id":698870,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27190,"kind":"person","name":"Molnar Dennis Patrick","position":1,"cik":"0001822371","reported_name":"Molnar Dennis Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:03.000Z","date":"2026-07-30","kind":"grant","planned":false,"acquired":true,"shares":55596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 24 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":55596,"derivative":{"exercise_price":16,"expiration_date":"2036-07-29","underlying":"Class A Common Stock","underlying_shares":55596},"source":{"system":"sec-edgar","filing":"0001193125-26-330502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330502/ownership.xml","form_type":"4"}},{"id":698869,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27190,"kind":"person","name":"Molnar Dennis Patrick","position":1,"cik":"0001822371","reported_name":"Molnar Dennis Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:03.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":12231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after September 17, 2025, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":12231,"derivative":{"exercise_price":8.88,"expiration_date":"2035-09-19","underlying":"Common Stock","underlying_shares":12231},"source":{"system":"sec-edgar","filing":"0001193125-26-330502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330502/ownership.xml","form_type":"4"}},{"id":698868,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27190,"kind":"person","name":"Molnar Dennis Patrick","position":1,"cik":"0001822371","reported_name":"Molnar Dennis Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:03.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after September 17, 2025, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":8.88,"expiration_date":"2035-09-19","underlying":"Class A Common Stock","underlying_shares":12231},"source":{"system":"sec-edgar","filing":"0001193125-26-330502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330502/ownership.xml","form_type":"4"}},{"id":698867,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27190,"kind":"person","name":"Molnar Dennis Patrick","position":1,"cik":"0001822371","reported_name":"Molnar Dennis Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy) Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:03.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":37064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 21, 2023, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":37064,"derivative":{"exercise_price":4.87,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":37064},"source":{"system":"sec-edgar","filing":"0001193125-26-330502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330502/ownership.xml","form_type":"4"}},{"id":698866,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27190,"kind":"person","name":"Molnar Dennis Patrick","position":1,"cik":"0001822371","reported_name":"Molnar Dennis Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:03.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":37064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 21, 2023, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":4.87,"expiration_date":"2033-12-21","underlying":"Class A Common Stock","underlying_shares":37064},"source":{"system":"sec-edgar","filing":"0001193125-26-330502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330502/ownership.xml","form_type":"4"}},{"id":698865,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27190,"kind":"person","name":"Molnar Dennis Patrick","position":1,"cik":"0001822371","reported_name":"Molnar Dennis Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:03.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":28539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 22, 2022, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":28539,"derivative":{"exercise_price":4,"expiration_date":"2032-12-22","underlying":"Common Stock","underlying_shares":28539},"source":{"system":"sec-edgar","filing":"0001193125-26-330502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330502/ownership.xml","form_type":"4"}},{"id":698864,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27190,"kind":"person","name":"Molnar Dennis Patrick","position":1,"cik":"0001822371","reported_name":"Molnar Dennis Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:03.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 22, 2022, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":0,"derivative":{"exercise_price":4,"expiration_date":"2032-12-22","underlying":"Class A Common Stock","underlying_shares":28539},"source":{"system":"sec-edgar","filing":"0001193125-26-330502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330502/ownership.xml","form_type":"4"}},{"id":698863,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27190,"kind":"person","name":"Molnar Dennis Patrick","position":1,"cik":"0001822371","reported_name":"Molnar Dennis Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:03.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":37064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to such option are fully vested."}],"balance_after":37064,"derivative":{"exercise_price":2.74,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":37064},"source":{"system":"sec-edgar","filing":"0001193125-26-330502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330502/ownership.xml","form_type":"4"}},{"id":698862,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27190,"kind":"person","name":"Molnar Dennis Patrick","position":1,"cik":"0001822371","reported_name":"Molnar Dennis Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:03.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":37064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to such option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.74,"expiration_date":"2032-06-14","underlying":"Class A Common Stock","underlying_shares":37064},"source":{"system":"sec-edgar","filing":"0001193125-26-330502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330502/ownership.xml","form_type":"4"}},{"id":698861,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27190,"kind":"person","name":"Molnar Dennis Patrick","position":1,"cik":"0001822371","reported_name":"Molnar Dennis Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:03.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":148788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to such option are fully vested."}],"balance_after":148788,"derivative":{"exercise_price":1.06,"expiration_date":"2030-03-31","underlying":"Common Stock","underlying_shares":148788},"source":{"system":"sec-edgar","filing":"0001193125-26-330502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330502/ownership.xml","form_type":"4"}},{"id":698860,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27190,"kind":"person","name":"Molnar Dennis Patrick","position":1,"cik":"0001822371","reported_name":"Molnar Dennis Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:03.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":148788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to such option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.06,"expiration_date":"2030-03-31","underlying":"Class A Common Stock","underlying_shares":148788},"source":{"system":"sec-edgar","filing":"0001193125-26-330502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330502/ownership.xml","form_type":"4"}},{"id":698859,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27190,"kind":"person","name":"Molnar Dennis Patrick","position":1,"cik":"0001822371","reported_name":"Molnar Dennis Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:03.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":42240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to such option are fully vested."}],"balance_after":42240,"derivative":{"exercise_price":1,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":42240},"source":{"system":"sec-edgar","filing":"0001193125-26-330502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330502/ownership.xml","form_type":"4"}},{"id":698858,"issuer":{"id":4910,"kind":"organization","name":"Apnimed, Inc."},"owners":[{"id":27190,"kind":"person","name":"Molnar Dennis Patrick","position":1,"cik":"0001822371","reported_name":"Molnar Dennis Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-03T20:01:03.000Z","date":"2026-08-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":42240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to such option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":1,"expiration_date":"2030-01-29","underlying":"Class A Common Stock","underlying_shares":42240},"source":{"system":"sec-edgar","filing":"0001193125-26-330502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745648/000119312526330502/ownership.xml","form_type":"4"}}],"next_cursor":"2026-08-03T20:01:03.000000Z,698858"}